Professor Joseph Pagano, BW Fund

Prof Pagano collaborated with Elion re the effects of acyclovir on the Epstein Bar virus. The interview focuses on the scientific and research aspects of the company.

Topics disucssed include:

* Fred Coe

* Pedro Cuatrecasas: work; relationship with Bill Sullivan; departure from BW; career with Glaxo and then Warner-Lambert;

* David Barry: changes within structure of department; work

* merger with Glaxo, nature of BW before merger

* acyclovir - marketing and development

* development of Retrovir and AZT, future of anti-HIV[Aids] therapy

1 audiocassette Tape 22 side B

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.